3M™ Integrated Dose by Dose Counter and the 3M™ Nasal Metered Dose Inhaler (MDI) - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

3M Drug Delivery: Partner with the Expert

3M™ Integrated Dose by Dose Counter and the 3M™ Nasal Metered Dose Inhaler (MDI)

As inventors of the very first metered dose inhaler (MDI), and being behind the latest MDIs, 3M has been at the forefront of inhalation technology for over 50 years. Our experience spans the entire system, from feasibility to selecting the right components – through to commercial scale production.

3M supports pharmaceutical customers globally providing a competitive edge with patient-centered innovations and devices that set our customers apart. Whether you’re looking for a primary contract fill manufacturer, a second source of supply, for cold or pressure fill, our trusted cGMP manufacturing capabilities provide you with reassurance that your product will be available for market.

We take the risk out of commercializing your new product, from start to finish.

Watch our video and learn more

Company name:  3M Drug Delivery Systems

Website: Watch our video and learn more

E-mail: DDS@mmm.com
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FindPharma Custom Search

Click here